Biotech Values

[randychub]

Some more info:

I believe an in expensive test with a 90% or better rate would probably do fine. You can look at nmp22, pap smears, and for that matter very expensive mamograms or colonoscopy's, cystoscopy, etc. as a guidline. Patients reaching a certain age, symptoms, past personnel history or family history would probably all use these tests. The could be used as a tracking device or to be used along with current standard care.

Matritech’s technology (as shown with minimum testing) is more accurate, less invasive, and will cost the user less than existing tests such as cystoscopy, colonoscopy, and mammography


Also don't rule out the fact that those patients that tested positive had undetectable cancer using current detection methods. The dcis accuracy was very good.

Compare the psa test with nmp48, a third of those who test positive for prostate cancer using PSA are healthy and, more seriously, a third of those who are PSA-negative have cancer.


In addition to receiving FDA approval for its initial tests, Matritech has successfully secured reimbursement rates for these tests under Medicare.

Price comparisons


Note the test price ($15):
Bladder NMP22 New cases to be tested each year 2,000,000 14,000,000 27,200,000
Monitoring existing cases 1,400,000 2,800,000 5,400,000
Total number of tests 3,400,000 16,800,000 32,600,000
Cystoscope clinical cost per test 150.00 $ 150.00 150.00
Total cost of cystoscopy 510,000,000 2,520,000,000 4,890,000,000
Price of Matritech test 8.00 $ 8.00 8.00
Potential market 27,200,000 134,400,000 260,800,000

Breast NMP66 Number of mammograms per year 32,000,000 62,000,000 86,800,000
Mammogram clinical cost per patient 125.00 $ 125.00 125.00
Total cost of mammorgraphy 4,000,000,000 7,750,000,000 10,850,000,000
Price of Matritech test 25.00 $ 25.00 25.00
Potential market 800,000,000 1,550,000,000 2,170,000,000

Cervical NMP179 Number of Pap smears per year 3,500,000 105,000,000 147,000,000
Pap smear clinical cost per patient 50.00 $ 50.00 50.00
Total cost of Pap smears 175,000,000 5,250,000,000 7,350,000,000
Price of Matritech test 15.00 $ 15.00 15.00
Potential market 52,500,000 1,575,000,000 2,205,000,000

Prostate NMP48 Number of PSA tests per year 1,166,667 33,000,000 56,100,000
PSA clinical cost per patient 30.00 $ 30.00 30.00
Total cost of PSA tests 35,000,000 990,000,000 1,683,000,000
Price of Matritech test 12.50 $ 12.50 12.50
Potential market 14,583,333 412,500,000 701,250,000

Colorectal NMP35 Number of colonoscopies per year 1,000,000 116,000,000 160,100,000
Colonoscopy clinical cost per patient 1,000.00 $ 1,000.00 1,000.00
Total cost of colonoscopy 1,000,000,000 116,000,000,000 160,100,000,000
Price of Matritech test 12.50 $ 12.50 12.50
Potential market 12,500,000 1,450,000,000 2,001,250,000
Potential number of tests per year 41,100,000 332,800,000 482,600,000

Total clinical pricing using established methods 5,720,000,000 132,510,000,000 184,873,000,000
Total Matritech potential market 906,800,000 5,121,900,000 7,338,300,000
Weighted average cost of Matritech tests 22.06 $ 15.39 15.21


I put that information in here just to show the current costs vs what nmp testing would cost. I know more then one doctor that has told me this would be a great thing to have and that if these rates held up they would use them ALOT.

I still question if this testing will ever be available in mass spec. and if the accuracy will hold up with in clinc testing. But if it does it will do more for cancer patients then any other investment I have made.
R